Scott Gottlieb, the FDAs former commissioner, said on CNBC that many of the compounds wont deliver the expected benefit. The agencys safety concerns appear to be well founded: between February 2019 and December 2023, the FDA received 352 adverse event reports related to compounded GLP-1 drugs, including five deaths
Weight loss from these medications can occur so rapidly that the skin doesnt have time to catch up, leading to sagging and a loss of firmness
The TriNetX database provided a comprehensive resource, encompassing complete diagnostic codes, medications prescribed, and procedures undertaken, facilitating a thorough analysis
Clinically Proven: Real GLP-1 medications such as semaglutide and tirzepatide
Hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) are potential complications
Constipation or diarrhea may occur as GLP-1 slows gastric motility, and the change in eating patterns affects gut transit time
